PT66514B - Process for long acting preparation of cefalexin for effective treatments of bacterial infections sensitive to cefalexin - Google Patents

Process for long acting preparation of cefalexin for effective treatments of bacterial infections sensitive to cefalexin

Info

Publication number
PT66514B
PT66514B PT66514A PT6651477A PT66514B PT 66514 B PT66514 B PT 66514B PT 66514 A PT66514 A PT 66514A PT 6651477 A PT6651477 A PT 6651477A PT 66514 B PT66514 B PT 66514B
Authority
PT
Portugal
Prior art keywords
cefalexin
bacterial infections
long acting
effective treatments
acting preparation
Prior art date
Application number
PT66514A
Other languages
English (en)
Portuguese (pt)
Other versions
PT66514A (en
Inventor
Hideyuku Maekawa
Yasushi Takagishi
Hiroshi Kato
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of PT66514A publication Critical patent/PT66514A/pt
Publication of PT66514B publication Critical patent/PT66514B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
PT66514A 1976-05-13 1977-05-05 Process for long acting preparation of cefalexin for effective treatments of bacterial infections sensitive to cefalexin PT66514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (2)

Publication Number Publication Date
PT66514A PT66514A (en) 1977-06-01
PT66514B true PT66514B (en) 1978-10-16

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
PT66514A PT66514B (en) 1976-05-13 1977-05-05 Process for long acting preparation of cefalexin for effective treatments of bacterial infections sensitive to cefalexin

Country Status (27)

Country Link
JP (1) JPS52139713A (es)
AR (1) AR224494A1 (es)
AT (1) AT351159B (es)
AU (1) AU508793B2 (es)
BE (1) BE854640A (es)
CA (1) CA1085296A (es)
CS (1) CS208196B2 (es)
DD (1) DD132232A5 (es)
DE (1) DE2721785A1 (es)
DK (1) DK208077A (es)
ES (1) ES458710A1 (es)
FI (1) FI771491A (es)
FR (1) FR2350836A1 (es)
GB (1) GB1543543A (es)
GR (1) GR68895B (es)
HU (1) HU184196B (es)
IE (1) IE45415B1 (es)
IL (1) IL52075A (es)
MX (1) MX5976E (es)
NL (1) NL7704879A (es)
NZ (1) NZ183927A (es)
PL (1) PL111183B1 (es)
PT (1) PT66514B (es)
RO (1) RO72935A (es)
SE (1) SE426780B (es)
SU (1) SU1218919A3 (es)
ZA (1) ZA772757B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Also Published As

Publication number Publication date
AT351159B (de) 1979-07-10
IL52075A (en) 1980-06-30
GR68895B (es) 1982-03-15
GB1543543A (en) 1979-04-04
JPS5547611B2 (es) 1980-12-01
IE45415B1 (en) 1982-08-25
ES458710A1 (es) 1978-03-01
FR2350836B1 (es) 1981-02-06
CS208196B2 (en) 1981-08-31
PT66514A (en) 1977-06-01
ATA341877A (de) 1978-12-15
SE7705502L (sv) 1977-11-14
IE45415L (en) 1977-11-13
RO72935A (ro) 1982-07-06
DD132232A5 (de) 1978-09-13
AU508793B2 (en) 1980-04-03
DE2721785C2 (es) 1989-03-16
NZ183927A (en) 1980-02-21
HU184196B (en) 1984-07-30
MX5976E (es) 1984-09-12
PL111183B1 (en) 1980-08-30
JPS52139713A (en) 1977-11-21
DE2721785A1 (de) 1977-11-24
AR224494A1 (es) 1981-12-15
BE854640A (fr) 1977-09-01
NL7704879A (nl) 1977-11-15
PL198058A1 (pl) 1979-03-26
DK208077A (da) 1977-11-14
SU1218919A3 (ru) 1986-03-15
ZA772757B (en) 1978-04-26
IL52075A0 (en) 1977-07-31
SE426780B (sv) 1983-02-14
FI771491A (es) 1977-11-14
CA1085296A (en) 1980-09-09
AU2507877A (en) 1978-11-16
FR2350836A1 (fr) 1977-12-09

Similar Documents

Publication Publication Date Title
PH18704A (en) Method of treatment using inidazo-rifamycin derivatives with antibacterial utility
JPS5320487A (en) Purification of bacterial lipoproteinlypase
SG4083G (en) 9-deoxy-9a-methylene isosteres of pg12
PT66514A (en) Process for long acting preparation of cefalexin for effective treatments of bacterial infections sensitive to cefalexin
AU515012B2 (en) Transfer of data to parallel processors
PH12620A (en) Treatment of infections
AU505867B2 (en) Treatment of ruminants
JPS52124679A (en) Transfer device of piece to be treated
JPS5337575A (en) Purification of aqueous solutions
JPS5341412A (en) Purification of extract including uterussevacuant
AU507698B2 (en) Purification of acrylamide
IL52320A0 (en) P-isobutzyl hydratropate of guyiycol and process for its preparation
PH17164A (en) Long acting preparation of cefalexin for effective treatment of bacterial infection sensitive to cefalexin
JPS5278878A (en) Method of reducing 44oxopiperidines to 44hydroxypiperidines
JPS56893A (en) Treatment of moxious matter compound
ZA82654B (en) Treatment of infections
JPS5278877A (en) Method of reducing 44oxopiperidines to 44hydroxypiperidines
JPS5696725A (en) Method of processing nephelite to alumina
JPS5341245A (en) Method of processing adhesive polarizer
JPS52974A (en) Method of elongating films of polyyepsilonncaproamide
AU265989B2 (en) Purification of 4 : 4' - bipyridyl
GB1539959A (en) Method of reducing zirconium
JPS53139722A (en) Mitecide for diagnosing and treating infection of honeybee according to external zooparasite
GB1516380A (en) Purification of aminophenols
AU2756063A (en) Purification of 4 : 4' - bipyridyl